Investigational Drug Information for Fallypride
What is the development status for investigational drug Fallypride?
Fallypride is an investigational drug.
There have been 19 clinical trials for Fallypride.
The most recent clinical trial was a Phase 3 trial, which was initiated on April 1st 2005.
The most common disease conditions in clinical trials are Schizophrenia, Alcoholism, and Obesity. The leading clinical trial sponsors are National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Emory University, and University of California, Irvine.
Summary for Fallypride
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 51 |
| WIPO Patent Applications | 18 |
| Japanese Patent Applications | 1 |
| Clinical Trial Progress | Phase 3 (2005-04-01) |
| Vendors | 28 |
Recent Clinical Trials for Fallypride
| Title | Sponsor | Phase |
|---|---|---|
| Neurobiological Mechanisms of Pathological Rumination and Effects of Aripiprazole | National Natural Science Foundation of China | NA |
| Neurobiological Mechanisms of Pathological Rumination and Effects of Aripiprazole | Second Xiangya Hospital of Central South University | NA |
| Neurobiological Mechanisms of Pathological Rumination and Effects of Aripiprazole | Central South University | NA |
Clinical Trial Summary for Fallypride
Top disease conditions for Fallypride
Top clinical trial sponsors for Fallypride
US Patents for Fallypride
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
